Zevra Therapeutics, Inc. (ZVRA) Profit Margins
Over the twelve months to 2026-06-30, Zevra Therapeutics, Inc. (ZVRA) had gross margin 95.5%, operating margin 60.5%, net margin 42.8%, free cash flow margin 24.0%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
ZVRAZevra Therapeutics, Inc.Follow ZVRA — free
—
Price chart with a free account
- Market cap
- 582.6M
- P/E TTM
- 10.7
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 3 Nov, in 10 days
| Line | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 22.1% | — | — | 97.8% | 89.3% | 68.6% | 84.5% | 95.5% | |
| Operating margin | -158.4% | -42.2% | 27.0% | -418.9% | -180.6% | -368.5% | -59.1% | 60.5% | |
| Net margin | -191.0% | -96.0% | -29.9% | -263.5% | -167.7% | -446.9% | 78.2% | 42.8% | |
| FCF margin | -185.1% | -14.8% | 36.1% | -185.1% | -123.2% | -295.0% | -2.3% | 24.0% |
USD millions · SEC XBRL
Zevra Therapeutics, Inc. — questions
- What is Zevra Therapeutics, Inc.'s gross margin?
- 95.5% over the twelve months to 2026-06-30.
- What is Zevra Therapeutics, Inc.'s operating margin?
- 60.5% over the twelve months to 2026-06-30.
- What is Zevra Therapeutics, Inc.'s net profit margin?
- 42.8% over the twelve months to 2026-06-30.
Every figure on this page comes from Zevra Therapeutics, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.